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IN VIVO EFFICACY EVALUATION FOR AN ALCOHOL-BASED HAND RUB
(ABHR) AGAINST HUMAN NOROVIRUS SURROGATES
Yutaka Nishihara a, Eiji Tominaga a, Tomofumi Ueda a, Takumi Kajiura a,
Ryuichi Sato a, Hideki Wada a, Maki Takizawa a, Katsuhiro Yokota a,
Maren Eggers b, S.Steve Zhou c. aYoshida Pharmaceutical Co., Ltd., Tokyo,
Japan; bLabor Prof. Gisela Enders MVZ GbR Virologie, Stuttgart, Germany;
cMicroBioTest Division, Microbac Laboratories, Inc., VA, USA
Purpose: Hand hygiene is a crucial measure for infection control to prevent
transmission of pathogens causing acute infectious gastroenteritis through
contaminated hands. We mainly report here a battery of virucidal efficacy
data through determining human norovirus surrogate-eliminating activity
in vivo for a newly-improved Alcohol-Based Hand Rub (ABHR) and also focus
on testing-methodological aspects from the standpoint of standardization in
Japan.
Methods: A newly-improved ABHR was evaluated according to ASTM E 2011-
13 in vivo. Virucidal assays were also conducted against varieties of strains
including non-enveloped viruses according to the testing methodology of
ASTM E 1052-11 in vitro.
Results: The ABHR demonstrated significant efficacies of greater than 2.30 
0.28 log10 reduction against Feline calicivirus and of 2.48  0.47 log10 reduc-
tion against Murine norovirus as surrogates for human norovirus relative to
baseline viral populations based on the in vivo testing method (p < 0.05)
and met the criteria of Health Canada’s guidance in 2009. A series of efficacy
data against 10 kinds of viruses including Feline calicivirus (more than 4.97
log10 reduction) and Murine norovirus (2.75 log10 reduction) in 15 second
were also given in vitro.
Conclusions: From the study results, it was found the novel ABHR had a po-
tential to pass the efficacy criteria of the guidance of Health Canada.
Furthermore, we presented a possibility to choose a testing method based
on outline of European committee for standardization (CEN) protocol as a
standardized methodology in Japan for in vivo virucidal efficacy evaluation
in the future.PS 2-344
DIFFICULT-TO-TREAT LIFE-THREATENING CMV PNEUMONIA: A CASE
REPORT
Mei-Yu Su a, Wen-Liang Yu a,b, Che-Kim Tan a. aDepartment of Intensive
Care Medicine, Taiwan; bChi-Mei Medical Center, Tainan City, Taiwan
Purpose: Cytomegalovirus (CMV) infection occurs in 0 to 36% of critically ill
patients, mostly between 4 and 12 days after intensive care units (ICU)
admission. Treatment of CMV pneumonia may be difficult. We report a
case of treatment failure of CMV pneumonia.
Case report: A 66-year-old man of nephrotic syndrome, chronic kidney dis-
ease (CKD), diabetes mellitus, adrenal insufficiency with regular control at
our OPD suffered from dysuria with decreased urine output for 3 days. He
was brought to emergency department on September 8, 2014. Laboratory
data shows leukocytosis, creatinine 7.51 mg/dL, and hyperkalemia. Emer-
gent hemodialysis and ceftriaxone were used. He was transferred to the
ward. Regular hemodialysis was used from perm-cath since September 17,
2014. Due to conscious change, brain CT was performed and showed small
deep old infarct. He was admitted to intensive care unit (ICU) on October
12, 2014. He received emergent endotracheal tube insertion with mechani-
cal ventilator use due to sudden onset of dyspnea and respiratory failure.
CXR showed worsening of mixed airspace and interstitial infiltration over
bilateral lungs. Sputum culture showed Pseudomonas aeruginosa. Antibiotic
was shifted to meropenem and tigecycline. Blood and sputum CMV-PCR
showed positive, CMV viral load was low-positive (<137 IU/mL). Aspergillus
Ag index showed 0.15 (negative). Ganciclovir was given on October 15, 2014.
Unstable BP was noted during hemodialysis. CXR showed mixed alveolar and
interstitial infiltration over both lungs, like pneumonia and adult respiratory
distress syndrome. Profound shock then developed requiring high dose vaso-
pressors on October 18, 2014. His condition remained worsening despite
aggressive treatment. Family members requested palliative therapy and
the patient expired on October 24, 2014.
Conclusion: Although the patient did not have cancer, organ transplantation
and AIDS, CKD with poorly responsive pneumonia may suspect CMVpneumonia. Anti-CMV immunoglobulin may be added to ganciclovir therapy
for life-threatening CMV pneumonia, particularly with pathologic diagnosis.PS 2-345
INTRANASAL VACCINATION WITH POLY(I:C) AND CPG AS ADJUVANTS
ENHANCES MUCOSAL AND SYSTEMIC IMMUNE RESPONSES TO AN
ENTEROVIRUS 71 VACCINE
Yu-Li Lin a, Szu-Min Hsieh b, Pei-Yun Cheng a, Hui-Ping Yuan a, Chiao-
Li Chin c, Bor-Luen Chiang c. aDepartment of Medical Research, National
Taiwan University Hospital, Taipei, Taiwan; bInternal Medicine, National
Taiwan University Hospital, Taipei, Taiwan; cDepartment of Pediatrics,
National Taiwan University Hospital, Taipei, Taiwan
Purpose: Mucosal vaccines can efficiently induce secretory IgA at mucosal
surfaces, thereby preventing or limiting infection at the site of virus entry.
Since Toll-like receptor (TLR) ligands can act as both the systematic and
mucosal adjuvants. Poly(I:C) is structurally similar to double-stranded
RNA, which is present in some viruses and is a stimulant of TLR3. CpG oligo-
deoxynucleotides (ODNs), resembling bacterial DNA, CpG could induce the
innate immune response through activation of TLR9. We used poly(I:C) and
CpG as adjuvants to study the Enterovirus 71 (EV71) mucosal vaccine.
Methods: Each mouse was intranasal immunized at 0, 3, and 6 weeks. To
evaluate the humoral immune responses, the anti-EV71 IgG and IgA were
assay, and the neutralization test were detected. To evaluate the cellular
immune responses, spleens were harvested to test the splenocyte prolifera-
tion and cytokines production.
Results: Our datas showed that EV71-specific IgA and IgG titers of serum,
nasal wash, BALF, and feces in EV71+poly(I:C)+CpG group was significantly
higher than EV71+poly(I:C) group or EV71+CpG group. Furthermore, there
were more EV71-specific IgA and IgG-producing cells in EV71 adjuvanted
with ploy(I:C)+CpG group. In addition, T-cell proliferative responses, IFN-
a˜, IL-10, and IL-17 secretion were significantly increased when the EV71
was formulated with poly(I:C)+CpG. More importantly, these antibodies
were able to neutralize the infectivity of EV71 (C2 genotype). They also
could cross-neutralized B4 and B5 genotype of EV71 infection.
Figure. Intranasal immunized EV71 with poly(I:C) and CpG to mice can
develop both specific humoral and cellular immune responses to EV71.
Conclusions: Our results indicated that poly(I:C) combined with CpG is an
effective intranasal adjuvant for EV71 vaccine, and IL-17 played an impor-
tant role in mucosal immunity.PS 2-346
COMPLIANCE AMONG CRITICAL CARE NURSES WITH PERFORMING ORAL
CARE PROTOCOLS FOR MECHANICALLY VENTILATED PATIENTS
Hsin-Lan Lin. Department of Nursing, Chi Mei Medical Center, Liouying,
Tainan, Taiwan
Purpose: This study examined the factors related to compliance among crit-
ical care nurses with performing oral care for mechanically ventilated pa-
tients in intensive care units.
Methods: This study was carried out at a regional teaching hospital
comprising a 63-bed adult intensive care unit (ICU) and a 20-bed subacute
respiratory care center (RCC). The protocol for oral care for mechanically
ventilated patients includes oral decontamination with 0.12% chlorhexidine
every eight hours (at the end of the day shift, the evening shift, and the
night shift).
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compliance, and a total of 759 oral care opportunities were observed,
including 278 opportunities at the end of the day shift, 267 at the end of
the evening shift, and 214 at the end of the night shift. The overall compli-
ance rate was 83.3%. Compliance with performing oral care was signifi-
cantly higher among nurses aged > 30 years, male nurses, nurses with
higher academic degrees, team leaders, senior RNs, and ICU licensed
nurses than among nurses & 30 years, female nurses, nurses with lower ac-
ademic degrees, non-team leaders, junior RNs, and non-ICU licensed nurses
(all P < 0.05). In contrast, years of experience in critical care settings and
VAP-associated education were not associated with oral care compliance.
Results of the multivariate analysis disclosed that age, academic degree,
ICU license, and location were independently associated with oral care
compliance.
Conclusions: Oral care compliance varied among nurses. Larger scale sur-
veillance studies are needed to identify the factors associated with compli-
ance among nurses with performing oral care for patients on mechanical
ventilation.PS 2-347
EVALUATION OF A CHLORINE DIOXIDE WATER TREATMENT SYSTEM TO
CONTROL LEGIONELLA SPECIES IN A HOSPITAL WATER SYSTEM
Yao-Ru Tseng a, Tsen - Lu Cho b, Kuei-Chu Li b, Hsiu-Shen Lin a, Kao-
Pin Hwang b,c, Ni Tien a. aDepartment of Laboratory Medicine, Department
of Medical Laboratory Science and Biotechnology, Taiwan; bCommittee of
Infection Control, Taiwan; cDivision of Pediatric Infectious Disease,
Department of Pediatrics, China Medical University Hospital, China Medical
University School Medicine, Taichung, Taiwan
Purpose: The contamination of the water supply system by Legionella, so
often results in health care associated pneumonia events. In order to
exclude the pathogens in the water supply system, often used in medical in-
stitutions of copper and silver ions exchange, chlorine dioxide, ozone or sin-
gle filters and other disinfection methods. With expert recommendations,
reference literature, and take into some issues such as hospital facilities
and the building position, we use chlorine dioxide disinfection methods for
water disinfection in hospitals.
Methods: We monitored the Legionella colonies in the chilled water system.
A medical center in central Taiwan since January 2013, in hospital water sys-
tems began to routinely monitor growing concentration of Legionella. In
April of 2013 began the installation of chlorine dioxide produced machines
system, maintaining the concentration of chlorine dioxide in hospital water
systems.Water samples were collected for Legionella enumeration by a stan-
dardized culture method. Routine environmental cultures were performed
to evaluate the efficacy.
Results: From January 2013 the detection rate was 20%, by 2014 to July, had
16 consecutive months with no detectable Legionella.
Conclusions: According to our monitoring results indicate that chlorine diox-
ide disinfection method used in chilled water system of hospital had the
effectiveness of control Legionella.By treatment using ClO2, we could con-
trol Legionella colonization rate in the test building.PS 2-348
ROLE OF LABORATORY IN DETECTION, EFFECTIVE MANAGEMENT AND
CONTROL OF OUTBREAKS OF HOSPITAL ASSOCIATED INFECTIONS
Terrence R. Chinniah, Kavitha Prabu, Amalina Sidek, Rashidah Ahamed.
Division of Microbiology, Department of Pathology, Raja Isteri Pengiran
Anak Saleha (RIPAS) Hospital, Bandar Seri Begawan, Brunei Darussalam,
Brunei
Purpose: Laparoscopic cholecystectomy reduces morbidity, mortality and
duration of stay. Laparascope is delicate with multiple channels, hence
cleaning and sterilization is tedious. If not done properly it can be a source
of cross infection among patients.
Methods: All gall bladders removed by laparoscopic cholecystectomy are
sent to microbiological laboratory. They are cultured according to routine
laboratory methods and isolated organisms are identified by VITEK 2,
API20E and API20NE. Antibiotic sensitivity is performed according to Clinical
Laboratory Standard Institute (CLSI) guidelinesResults: During the period from March 2012 occasional isolations of Serratia
marcescens went unnoticed. In September 2012, within a span of 20 days,
Serratia marcescens were isolated from eight gall bladders following laparo-
scopic cholecystectomy. One of these 8 patients was re-admitted with surgi-
cal site infection with Serratia marcescens and another patient who didn’t
grow Serratia marcescens from the removed gall bladder was admitted
with Serratia marcescens septicemia Similar antibiogram of all these isolates
lead to a suspicion of an outbreak.
This was investigated and infection control practices including cleaning,
disinfection and sterilization of endoscopes were revisited and performed.
Environmental samples and specimens sent from the endoscopes and
solutions were negative for Serratia marcescens prior and after the interven-
tion. Following these interventions no single Serratia marcesens was isolated
from laparoscopic cholecystectomy patients to date.
Conclusion: Meticulous vigilant monitoring of isolates from specimens can
help to identify an outbreak and will help the infection control unit to con-
trol it. Hence the role of laboratory in identifying them early is essential.
Though environmental samples and specimens sent from the endoscopes
and solutions were negative, the absence of Serratia marcesens, to date,
from any specimens following laparoscopic cholecystectomy, emphasis the
need of proper cleaning disinfection and sterilization. Continuous education
on infection control policies and monitoring of the aseptic preparation are
necessary for personnel involved.PS 2-349
IS TIGECYCLINE PRESCRIBED TO TREAT CARBAPENEM-RESISTANT
ACINETOBACTER BAUMANNII COMPLICATED URINARY TRACT
INFECTIONS
Chao-Tai Lee a, Hung-Ming Chu a, Chin-Lu Chang b. aDepartment of Clinical
laboratory, Taiwan; bCommittee of Infection Control, Tainan Municipal
Hospital, Tainan, Taiwan
Purpose: In general, carbapenem-resistant Acinetobacter baumannii (CRAB)
is resistant most of antibiotics, except tigecycline and colistin. Colistin has
nephrotoxicity, so it is inappropriate antibiotic in some conditions, such as
in patients with renal impairment. Tigecyeline has low urinary concentra-
tion, so it is not usually recommended to treat complicated urinary tract in-
fections (cUTI). Hence, in case of CRAB cUTI, the treatment options are
severe limited. In this study, we reported two cases of CRAB cUTI success-
fully treated with two different dose of tigecycline.
Methods: We reported two cases of CRAB cUTI treated with tigecycline, 50
mg and 100 mg, respectively, every 12 hours for 14 days. Standard disk diffu-
sion method was used for antimicrobial susceptibility testing. The interpre-
tation of tigecycline against A. baumannii isolates was according to the U.S.
Food and Drug Administration interpretive criteria for Enterobacteriaceae
(susceptible, minimal inhibitory concentration&2 mg/ml).
Results: The two A. baumannii isolates were only susceptible to tigecycline
(colistin was not tested). The two cases of CRAB cUTI treated with tigecy-
cline were clinical treatment success; however, both repeated urine cul-
tures were still positive with CRAB.
Conclusions: As the above mentioned, the treatment options for CRAB cUTI
are limited. In our option, tigecycline may be prescribed to treat CRAB cUTI,
especially in case of no other appropriate antibiotics available. The reason
of clinical treatment success may be tigecycline having good renal concen-
tration. In contrast, the reason of being unable to eradicate CRAB may be
it having low urinary concentration.PS 2-350
THE HEALTH-CARE ASSOCIATED INFECTION IN VENTILATOR-DEPENDENT
PATIENTS: THE IMPACT OF WEANING
Shu-Chien Liang a, Mei-Ju Chi b, Ming-Han Tsai c, You-Lan Yang d. aKeelung
Hospital, Ministry of Health and Welfare, Taiwan; bTaipei Medical
University, Taiwan; cChang Gung Memorial Hospital, Taiwan; dTaipei
Medical University, Taiwan
Purpose: According to the National Health Insurance Administration, there
were 11,573 people dependent ventilator. The Huge medical costs, and
70e80% of patients are unconscious, and the cost of waste caused an invalid
medical controversy. Therefore, improving the prognosis of ventilator-
